Anavex Life Sciences Corp. (AVXL)
3.80
+0.15
(+4.11%)
USD |
NASDAQ |
Dec 30, 16:00
3.79
-0.01
(-0.26%)
After-Hours: 20:00
Anavex Life Sciences Market Cap: 339.52M for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vanda Pharmaceuticals, Inc. | 415.45M |
| CorMedix, Inc. | 983.29M |
| Verastem, Inc. | 567.91M |
| ADMA Biologics, Inc. | 4.370B |
| Aldeyra Therapeutics, Inc. | 309.84M |
Market Cap Related Metrics
| PEG Ratio | -1.218 |
| Price to Book Value | 3.579 |
| Price | 3.80 |
| Earnings Yield | -14.31% |
| PEGY Ratio | -1.218 |